Skip to content

Anesthesia and Early Recovery in Ankle Arthroscopy: A Comparative Study

Comparison of Total Intravenous, Balanced, and Spinal Anesthesia for Early Recovery Following Ankle Arthroscopy: A Multicenter, Prospective, Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119532
Enrollment
Unknown
Registered
2026-02-28
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle sprain, ankle instability, ATFL tear

Interventions

General anesthesia:Combined intravenous and inhalation general anesthesia with preoperative peripheral nerve block
TIVA-P + PNB group:Total Intravenous Anesthesia combined with Peripheral Nerve Block

Sponsors

The second affiliated hospital of Zhejiang University school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Full understanding of the study procedures and methods, with voluntary provision of written informed consent. 2. Aged 18 to 65 years, of either sex. 3. Scheduled for elective unilateral minimally invasive ankle surgery. 4. American Society of Anesthesiologists (ASA) physical status classification I or II. 5. Body Mass Index (BMI) between 16 and 32 kg/m^2;

Exclusion criteria

Exclusion criteria: 1. Allergy to any study medication or presence of contraindications to anesthesia. 2. Chronic Obstructive Pulmonary Disease (COPD) or unstable asthma. 3. History of difficult airway management, poorly controlled Gastroesophageal Reflux Disease (GERD), or known risk of aspiration. 4. Surgery duration expected to exceed 3 hours. 5. History of chronic opioid use prior to surgery. 6. History of severe adverse reactions to anesthesia/surgery. 7. Pregnant or breastfeeding women. 8. Patients with a history of epilepsy. 9. Severe peripheral neuropathy. 10. Other conditions deemed by the investigator to make the patient unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Duration of stay in Phase I PACU;

Secondary

MeasureTime frame
The oral morphine equivalent (OME) of the total additional salvage consumption of acetaminophen and oxycodone within 24 hours postoperatively.;Area under the curve (AUC) of NRS pain scores within 24 hours postoperatively (measured at 2, 6, 12, 18, and 24 hours);Incidence of postoperative adverse reactions (nausea, vomiting, headache, urinary retention);Patient, surgeon, and anesthesiologist self-rating of anesthesia satisfaction;The 15-item Quality of Recovery (QoR-15) score;

Countries

China

Contacts

Public ContactPan Zongyou

The second affiliated hospital of Zhejiang University school of medicine

panzongyou@zju.edu.cn+86 19857004757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026